ARCHIVES

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Katterhagen Committee to Meet On PDQ Questions; ACS Grants Total Highest In History, $57 Million

August 19, 1983

Report Says Many Cancers Could Be Prevented

February 27, 2009

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002

A Transcript: what Fisher Knew, When Did He Know

June 24, 1994

NCI Programs: Institute To Expand Career Development, Training Grants

December 18, 1998

Columbus CCP Forms New Entity to Administer CCOP

July 20, 1990